Scott-Moncrieff & Associates, a UK-based law firm, has disclosed that it is preparing nearly 50 cases against pharmaceutical giant AstraZeneca (AZ, NASDAQ: AZN) in relation to its SARS-CoV-2 vaccine. The move follows the filing of a product liability claim by a plaintiff earlier this month, who alleged that his wife’s death was a result of receiving AstraZeneca’s vaccine. This week, another claimant filed a product liability lawsuit against the company after being diagnosed with vaccine-induced thrombotic thrombocytopenia (VITT), a potentially fatal condition that has previously been associated with the vaccine, leading to restrictions on its use in individuals under 40 years of age.
Firm’s Stance on Vaccine Safety and Regulatory Standards
While Scott-Moncrieff & Associates has declined to comment on the specifics of the court cases, it has emphasized the importance of the safe use of vaccines. The firm has stated that such safety is guaranteed by the clear and stringent standards set by regulatory authorities. This statement underscores the role of these authorities in ensuring that vaccines meet high safety and efficacy thresholds before they are administered to the public.-Fineline Info & Tech
